info@biomedres.us   +1 (720) 414-3554   600 Third Avenue, 2nd floor, New York - 10016, USA
ISSN: 2574 -1241

OpinionOpen Access

Institutional Review Board Roles and Functions to Conduct Clinical Trials at a Medium-Sized Regional Hospital, Japan

Volume 2 - Issue 1

Maki Ogawa1, Rie Matsumoto2 and Atsushi Imai3*

  • Author Information Open or Close
    • 1Clerk Support Unit for Physicians, Japan
    • 2Pharmaceutical Department, Japan
    • 3Institute of Endocrine-related Cancer, Matsunami General Hospital, Japan

    *Corresponding author: Atsushi Imai, Institute of Endocrine-related Cancer, Matsunami General Hospital, Kasamatsu, Gifu, Japan, Tel: 815823880111; Email: aimai@matsunami-hsp.or.jp

Received: December 21, 2017;   Published: January 05, 2018

DOI: 10.26717/BJSTR.2018.02.000634

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Clinical trials are a key resource for the discovery of new diagnostic, treatment and prevention methods for disease. Many of today’s most introduced prevention and treatment modalities are based on previous clinical trial results. Clinical trials are an important part of improving quality of health care [1]. Facilitators of participation in clinical trials have been linked to recommendations by reliable health care providers, a supportive family, satisfactory doctor-patient relationship that depends on culture, financial incentives, anticipation of a personal benefit to participants, convenience to participants and culturally appropriate advertisements [2]. To address such facilitators and barriers of clinical trial participation in communities, we report our institutional review board (IRB) of Matsunami General Hospital [3]. A typical central medical institution anchor of the region, Japan.

Keywords: IRB; Contracted Clinical Trial; Medical Institution Anchor of the Region; Medical Research

Introduction| References|